Extend the cannabis palliative exemption to all patients and their providers

What is this petition about?

This petition asks the New Zealand Parliament to change the Misuse of Drugs Act 1975. Currently, the law has a specific exemption (Section 8(6A)) that allows doctors to prescribe cannabis-based medicines to patients who are palliative (meaning they are nearing the end of their life and receiving care to manage symptoms). The petitioners want this exemption expanded so that any patient with a documented painful or debilitating condition can access these medicines, not just those in palliative care. It also seeks to protect the doctors and providers who prescribe or supply these products from legal penalties.

Current Situation in New Zealand

Under current law, cannabis is generally illegal to possess, use, or supply. However, there are narrow exceptions. The most significant is the palliative care exemption, which was introduced to help terminally ill patients manage severe pain and nausea. Outside of this specific exemption, accessing medical cannabis is difficult. While some patients may access products through clinical trials or specific regulatory pathways, there is no broad legal right for non-terminal patients to be prescribed cannabis for chronic pain, multiple sclerosis, or other debilitating conditions. This petition exists because advocates argue the current law is too restrictive for people suffering from long-term, non-terminal illnesses.

Arguments in Favour

• Access to Relief: Supporters argue that many people with chronic pain, epilepsy, or multiple sclerosis find relief in cannabis-based products, but currently lack a clear legal pathway to access them safely under medical supervision.
• Medical Autonomy: Proponents believe that if a doctor determines a treatment is beneficial and safe, the law should not prevent that prescription simply because the patient is not dying.
• Legal Clarity: Extending the exemption would provide legal protection for both patients and healthcare providers, reducing the risk of criminal charges for medical practice.

Arguments Against

• Public Health Concerns: Opponents, including some health professionals and government officials, worry that broadening access could lead to increased recreational use or misuse, particularly among vulnerable groups.
• Lack of Evidence: Critics argue that while there is evidence for palliative care, the scientific evidence for cannabis treating other chronic conditions is less conclusive or inconsistent, making broad prescription risky.
• Regulatory Complexity: There are concerns about how to regulate supply, quality, and dosage for a wider range of conditions without creating a black market or overwhelming the healthcare system.

Relevant Context

The Misuse of Drugs Act 1975 is the primary legislation controlling drugs in New Zealand. The palliative care exemption was a significant legislative update aimed at compassionate care. Recently, there has been growing public debate about drug policy in New Zealand, including discussions around decriminalisation and regulation. This petition targets a specific legal gap: the difference between end-of-life care and chronic disease management. The affected parties include patients with chronic pain, neurologists, palliative care specialists, and pharmacists.

⚡ Cached from a previous visit